Intervene Inc
Mountain View, US · Founded 2011 · Delaware corporation · 17 employees on LinkedIn · 4 known investors
InterVene, Inc. is a medical device company that has developed a fully integrated mechanical thrombectomy system to treat venous in-stent restenosis and residual thrombotic venous obstructions and occlusions. Its technology targets venous disease conditions such as postthrombotic syndrome that current therapies fail to address.
Founders & leadership
Intervene Inc was founded in 2011 by Fletcher Wilson.
FW
Fletcher WilsonFounder
EN
Evan NgSecretary
Board
TF
MS
Mel SchatzBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$11.1M disclosed across 4 rounds · 2015–2023
▶$1.5MraisedMar 2023 · 6 investors · Other Health CareRule 506(b)
▶$1.5MraisedMar 2023 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Adam BermanDirector
- Jeffrey ElkinsExecutive Officer, Director
- Catherine L. MatthesExecutive Officer
- Ginger GlaserDirector
- Joe BillerDirector
- Jay SchmelterDirector
- Fletcher WilsonDirector
- Offering amount
- $3M
- Amount sold
- $1.5M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedMar 2023 · 6 investors · Other Health CareRule 506(b)
▶$1.5MraisedMar 2023 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ginger GlaserDirector
- Fletcher WilsonDirector
- Jay SchmelterDirector
- Adam BermanDirector
- Catherine L. MatthesExecutive Officer
- Joe BillerDirector
- Jeffrey ElkinsExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.5M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedJun 2017 · 17 investors · Other Health CareRule 506(b)
▶$2.2MraisedJun 2017 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Evan NgExecutive Officer
- Thomas FogartyDirector
- Mel SchatzDirector
- Jay SchmelterDirector
- Fletcher WilsonExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $2.2M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.9MraisedMar 2015 · 52 investors · Other Health CareRule 506(b)
▶$5.9MraisedMar 2015 · 52 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mel SchatzDirector
- Thomas FogartyDirector
- Fletcher WilsonExecutive Officer, Director
- Evan NgExecutive Officer
- Offering amount
- $7.2M
- Amount sold
- $5.9M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapInnova Vascular20 shared keywordsInnova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
Rf Surgical19 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Boston Scientific17 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Companies competing with Intervene Inc for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Intervene Inc do?
- InterVene, Inc. is a medical device company that has developed a fully integrated mechanical thrombectomy system to treat venous in-stent restenosis and residual thrombotic venous obstructions and occlusions. Its technology targets venous disease conditions such as postthrombotic syndrome that current therapies fail to address.
- Who founded Intervene Inc?
- Intervene Inc was founded by Fletcher Wilson in 2011.
- Who are Intervene Inc's investors?
- Intervene Inc's investors include LaunchCapital, RiverVest Venture Partners, Treo Ventures, Llc, Emergent Medical Partners, LLP.
- How much funding has Intervene Inc raised?
- Intervene Inc has disclosed $11.1M raised across 4 rounds.
- Where is Intervene Inc headquartered?
- Intervene Inc is headquartered in Mountain View, US.